ITMI20001093A0 - Composizioni a rilascio controllato contenenti un principio attivo, preferibilmente melatonina, e processo di preparazione delle stesse. - Google Patents

Composizioni a rilascio controllato contenenti un principio attivo, preferibilmente melatonina, e processo di preparazione delle stesse.

Info

Publication number
ITMI20001093A0
ITMI20001093A0 IT2000MI001093A ITMI20001093A ITMI20001093A0 IT MI20001093 A0 ITMI20001093 A0 IT MI20001093A0 IT 2000MI001093 A IT2000MI001093 A IT 2000MI001093A IT MI20001093 A ITMI20001093 A IT MI20001093A IT MI20001093 A0 ITMI20001093 A0 IT MI20001093A0
Authority
IT
Italy
Prior art keywords
active ingredient
preparation process
controlled release
compositions containing
release compositions
Prior art date
Application number
IT2000MI001093A
Other languages
English (en)
Inventor
Bojidar M Stankov
Original Assignee
Ambros Pharma S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambros Pharma S R L filed Critical Ambros Pharma S R L
Priority to IT2000MI001093A priority Critical patent/IT1318524B1/it
Publication of ITMI20001093A0 publication Critical patent/ITMI20001093A0/it
Priority to US09/854,802 priority patent/US20040043065A1/en
Publication of ITMI20001093A1 publication Critical patent/ITMI20001093A1/it
Application granted granted Critical
Publication of IT1318524B1 publication Critical patent/IT1318524B1/it
Priority to US11/983,958 priority patent/US7858656B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
IT2000MI001093A 2000-05-17 2000-05-17 Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse. IT1318524B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000MI001093A IT1318524B1 (it) 2000-05-17 2000-05-17 Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.
US09/854,802 US20040043065A1 (en) 2000-05-17 2001-05-14 Controlled release formulations containing an active ingredient, preferably melatonin, and the method of preparation
US11/983,958 US7858656B2 (en) 2000-05-17 2007-11-13 Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001093A IT1318524B1 (it) 2000-05-17 2000-05-17 Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.

Publications (3)

Publication Number Publication Date
ITMI20001093A0 true ITMI20001093A0 (it) 2000-05-17
ITMI20001093A1 ITMI20001093A1 (it) 2001-11-19
IT1318524B1 IT1318524B1 (it) 2003-08-27

Family

ID=11445069

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI001093A IT1318524B1 (it) 2000-05-17 2000-05-17 Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.

Country Status (2)

Country Link
US (2) US20040043065A1 (it)
IT (1) IT1318524B1 (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080171085A1 (en) * 2007-01-11 2008-07-17 Natrol, Inc. Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
CA2681158C (en) 2007-03-13 2018-09-18 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
US20080254121A1 (en) * 2007-04-10 2008-10-16 Iomedix Sleep International Srl Multi-layer melatonin composition
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
IT1401142B1 (it) * 2010-07-26 2013-07-12 Ambros Pharma S R L Procedimento per la preparazione di compresse a rilascio controllato comprendenti melatonina
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
ITMI20110332A1 (it) * 2011-03-03 2012-09-04 Ambros Pharma S R L Formulazioni contenenti melatonina a rilascio pulsatile o sequenziale e procedimento per la loro preparazione
CN104840439B (zh) * 2014-02-17 2019-07-23 中国科学院上海药物研究所 一种褪黑素仿生释药制剂及其制备方法
ES2677247T3 (es) 2014-05-28 2018-07-31 Valpharma S.P.A. Formulación para administración oral que comprende melatonina en forma estable y método de producción de la misma
CN104546777A (zh) * 2014-12-16 2015-04-29 深圳翰宇药业股份有限公司 美乐托宁缓释组合物的制备方法、美乐托宁缓释片的制备方法
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
WO2019038586A1 (en) 2017-08-19 2019-02-28 Ftf Pharma Private Limited PHARMACEUTICAL COMPOSITION OF MELATONIN
CN109350605A (zh) * 2018-10-24 2019-02-19 中国药科大学 一种褪黑素迟释片及其制备方法
CN114259490A (zh) * 2021-12-23 2022-04-01 宁波玉健医药有限公司 一种褪黑素制剂及其制备方法
GB2617102A (en) * 2022-03-29 2023-10-04 John Hemming Trading Ltd Sleep therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2718020B1 (fr) * 1994-04-01 1996-05-31 Biotec Centre Sa Composition galénique mucoadhésive hétérofonctionnelle.

Also Published As

Publication number Publication date
IT1318524B1 (it) 2003-08-27
US20040043065A1 (en) 2004-03-04
ITMI20001093A1 (it) 2001-11-19
US20080187587A1 (en) 2008-08-07
US7858656B2 (en) 2010-12-28

Similar Documents

Publication Publication Date Title
ITTO20010005A1 (it) Formulazione farmaceutica.
ITMI20001093A0 (it) Composizioni a rilascio controllato contenenti un principio attivo, preferibilmente melatonina, e processo di preparazione delle stesse.
MX255941B (es) Derivado de isoxazolina y herbicida que lo contiene como ingrediente activo.
MXPA03003235A (es) Formulaciones farmaceuticas de liberacion retrasada.
HUS1300023I1 (hu) Antranil-amid-származékok, alkalmazásuk és a vegyületeket hatóanyagként tartalmazó artropodicid készítmények
ATE274299T1 (de) Pestizide formulierungen
ITTO20000963A0 (it) Microparticella a rilascio prolungato e metodo per la sua preparazione.
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
BR0113494B1 (pt) processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida.
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
MXPA03007215A (es) Formulaciones farmaceuticas.
DK1417206T3 (da) Hidtil ukendte 2H-pyridazin-3-on-derivater, farmaceutiske præparater indeholdende det samme, og en fremgangsmåde til fremstilling af den aktive bestanddel
NO20031597L (no) Medisinske aerosolformuleringer
DK1265482T3 (da) Vandige formulationer og fremgangsmåde til fremstilling af samme
MXPA03004980A (es) Delta 1-pirrolinas usadas como pesticidas.
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
NO20014050D0 (no) 1-aryl-1,3,5-triazin-4-tion-2,6-dioner, fremstilling derav og anvendelse derav som herbicider
ATE256727T1 (de) Stabile, eine silikonkomponente enthaltende wässrige zusammensetzungen
IL152533A0 (en) NOVEL FORMULATIONS OF alpha-2,4-DISULFOPHENYL-N-TERTBUTYLNITRONE
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel
NO20041878L (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
NO20030474D0 (no) Demens-legemiddel som inneholder 2-aryl-8- oksodihydropurinderivater som denaktive bestanddel
AU2001241067A1 (en) Omega-substituted phenyl-prostaglandin e-alcohols, process for producing the same and drugs containing the same as the active ingredient
IT1314233B1 (it) Vaccino per hiv.